Profile
John Edward Morley is the founder of Edunn Biotechnology, Inc. Prior to founding Edunn Biotechnology, he worked as a Staff Endocrinologist at the University of Minnesota and the VA Medical Center in the District of Columbia.
Before that, he held Principal positions at St. Louis University and the University of California, Berkeley.
Morley earned his doctorate degree from the University of the Witwatersrand in 1972.
Former positions of John Edward Morley
| Companies | Position | End |
|---|---|---|
| St. Louis University | Corporate Officer/Principal | - |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | Corporate Officer/Principal | - |
| University of California, Berkeley | Corporate Officer/Principal | - |
| VA Medical Center (District of Columbia) | Corporate Officer/Principal | - |
Edunn Biotechnology, Inc.
 Edunn Biotechnology, Inc. Pharmaceuticals: GenericHealth Technology Edunn Biotechnology, Inc. develops drugs to treat central nervous system diseases. The firm engages in developing oligonucleotide drugs to treat central nervous system diseases. The company was founded in September 2005 and is headquartered in St. Louis, MO. | Founder | - |
Training of John Edward Morley
| University of the Witwatersrand | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Edunn Biotechnology, Inc.
Edunn Biotechnology, Inc. Pharmaceuticals: GenericHealth Technology Edunn Biotechnology, Inc. develops drugs to treat central nervous system diseases. The firm engages in developing oligonucleotide drugs to treat central nervous system diseases. The company was founded in September 2005 and is headquartered in St. Louis, MO. | Health Technology |
| VA Medical Center (District of Columbia) | Government |
- Stock Market
- Insiders
- John Edward Morley
